Neurobiology of Psychedelics: Implication for Mood Disorders - Franz Vollenweider

Franz Vollenweider examines the neurobiological underpinnings of altered states of consciousness induced by psychedelics and their potential applications for treating mood disorders like depression. Core research focuses on the dimensions of these states, identifying how different substances create distinct neural patterns. Detailed studies using neuroimaging and psychometric tools reveal that psychedelics modulate sensory gating and emotional processing, providing insights into their therapeutic mechanisms. Research demonstrates that psilocybin and ketamine influence neural activity, particularly in brain regions critical for emotion and sensory perception. By mapping these changes, Vollenweider highlights how psychedelic-induced alterations in connectivity can potentially reconfigure dysfunctional brain circuits found in depressed patients, suggesting a move towards more targeted neurobiological interventions for psychiatric care.